Groww Logo
Home>IPO>Sigachi Industries Ltd.

Sigachi Industries IPO

Sigachi Industries Ltd.

₹14,490 /90 sharesMinimum Investment

IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹163.00₹570.00₹407.00 (249.69%)

IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
1 Nov ‘21 - 3 Nov ‘21₹14,49090₹161 - ₹163
Issue SizeIPO Doc
125.43Cr
RHP PDF

Subscription Rate As on 03 Nov '21, 5:00 PM

  • Retail Individual Investor
    80.49x
  • Non-Institutional Investor
    172.43x
  • Qualified Institutional Buyers
    86.51x

About Company

Sigachi Industries Ltd. started its business by manufacturing chlorinated paraffin and hydrochloric acid in its manufacturing unit situated in Hyderabad. Subsequently, it diversified into manufacturing microcrystalline cellulose (MCC) and commenced export operations. Currently, it manufactures around 59 different grades of MCC through its manufacturing units at Hyderabad and Gujarat.
... Read More
Parent Organisation
Sigachi Industries Ltd.
Founded
1989
Managing Director
Amit Raj Sinha
SJS Enterprises Limited IPO | Sigachi Industries IPO | Upcoming IPO

Strengths & Risks

  • With the help of its premium quality products, the company has been able to create a long-standing market presence in India and internationally.
  • Comprehensive product portfolio that allows it to serve diverse end-use applications.
  • Sigachi has developed long-term relationships with its customers in various sectors including pharmaceutical, nutraceuticals, food, and cosmetics.
  • Regular investments in research and development to expand its bouquet of product offerings and streamline the manufacturing process.
  • All products manufactured by Sigachi follow GMP norms to ensure that premium quality products are supplied to customers are competitive prices.
  • Its manufacturing facilities are strategically located.
  • The company enjoys certain benefits under the “Merchandise Exports from India Scheme” (MEIS) and “Duty Drawback Scheme” provided by the Central Government of India.
  • Since the company’s success is largely dependent upon its ability to develop innovative grades of cellulose-based excipients, any inability to innovate can make its portfolio redundant and impact profitability.
  • Dependence on the demand from the pharmaceutical industry for revenue.
  • Dependence on a few key suppliers for procuring major raw materials.
  • Since the company manufactures products that are used as raw material in other end-use products, any decline in the demand for the end-use products can have a direct impact on the revenue of Sigachi Industries.
  • The company has experienced negative cash flow in the past and might continue to do so in the future.
  • The company’s business and prospects might get adversely affected if it fails to maintain or grow its brand image.
  • Depleting natural resources might reduce the availability of raw materials or lead to an increase in costs.
  • The global scope of operations exposes the company to the risks of doing business in foreign countries.
  • Any failure in its quality control processes might adversely affect its business.

Financials

*All values are in Rs. Cr
No Graph Data To Display
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 2.0.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES: ICICI PRUDENTIAL  | HDFC  | NIPPON INDIA  | ADITYA BIRLA SUN LIFE  | SBI  | UTI  | FRANKLIN TEMPLETON  | KOTAK MAHINDRA  | IDFC  | DSP  | AXIS  | TATA  | L&T  | SUNDARAM  | PGIM  | INVESCO  | LIC  | JM FINANCIAL  | BARODA PIONEER  | CANARA ROBECO  | HSBC  | IDBI  | INDIABULLS  | MOTILAL OSWAL  | BNP PARIBAS  | MIRAE ASSET  | PRINCIPAL  | BOI AXA  | UNION KBC  | TAURUS  | EDELWEISS  | NAVI  | MAHINDRA  | QUANTUM  | PPFAS  | IIFL  | Quant  | SHRIRAM  | SAHARA | ITI
ABOUT GROWW